Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Frontiers in Endocrinology|February 2, 2017
Non-Genomic Actions of the Androgen Receptor in Prostate CancerJacky K Leung, Marianne D SadarHuman Cell|September 21, 2020
Isolation and characterization of castration-resistant prostate cancer LNCaP95 clonesJacky K Leung, Teresa Tam, Jun Wang, et al.Cancer Journal (Sudbury, Mass.)|August 6, 2025
Modulating Redox Biology to Improve Radiation ResponsesJacky K Leung, Ryan Panchal, Selvakumar Anbalagan, et al.Communications Biology|March 23, 2021
Pin1 inhibition improves the efficacy of ralaniten compounds that bind to the N-terminal domain of androgen receptorJacky K Leung, Yusuke Imamura, Minoru Kato, et al.Journal of Medicinal Chemistry|May 21, 2025
De Novo-Designed APC/C Inhibitors Provide a Rationale for Targeting RING-Type E3 Ubiquitin LigasesGloria Ruiz-Gómez, Alena Uvizl, Gabor Bakos, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2015
Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate CancerMinoru Kato, Carmen A Banuelos, Yusuke Imamura, et al.Molecular Cell|August 26, 2025
A redox switch in p21-CDK feedback during G2 phase controls the proliferation-cell cycle exit decisionJulia Vorhauser, Theodoros I Roumeliotis, David Coupe, et al.Cancers|July 26, 2020
Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice VariantsCarmen A Banuelos, Yusuke Ito, Jon K Obst, et al.JCI Insight|August 16, 2016
An imaging agent to detect androgen receptor and its active splice variants in prostate cancerYusuke Imamura, Amy H Tien, Jinhe Pan, et al.Pageof 1